Podchaser Logo
Home
Comparing Biologic Therapies for PsA: Rationales, Benefits, & Risks

Comparing Biologic Therapies for PsA: Rationales, Benefits, & Risks

Released Wednesday, 30th September 2020
Good episode? Give it some love!
Comparing Biologic Therapies for PsA: Rationales, Benefits, & Risks

Comparing Biologic Therapies for PsA: Rationales, Benefits, & Risks

Comparing Biologic Therapies for PsA: Rationales, Benefits, & Risks

Comparing Biologic Therapies for PsA: Rationales, Benefits, & Risks

Wednesday, 30th September 2020
Good episode? Give it some love!
Rate Episode

Guest: J. Eugene Huffstutter, MD

With multiple FDA-approved biologics available for patients with psoriatic arthritis, how do we decide which option is best for each patient? Rheumatologist Dr. Joseph Huffstutter details what biologic therapies we have to choose from and the rationale for choosing one over another.

Show More

Unlock more with Podchaser Pro

  • Audience Insights
  • Contact Information
  • Demographics
  • Charts
  • Sponsor History
  • and More!
Pro Features